Researchers at University of Rochester Medicine reported a study in the journal Developmental Cell. Darren Carpizo led the work. The team found a gene called Dec2 that helps pancreatic cancer cells hide from immune cells by changing a molecule on the cell surface. In lab tests, removing Dec2 let immune cells find and kill the cancer cells.
The researchers also found that Dec2 follows a daily, or circadian, rhythm. The time of day changed how well T cells killed the cancer cells. The study may explain why some immunotherapy works better in the morning. A small mRNA vaccine trial at Memorial Sloan Kettering helped some patients but not others.
Difficult words
- researcher — A person who studies and tests ideas.researchers
- gene — A part of a cell that gives instructions.
- immune cell — A body cell that fights infections and cancer.immune cells
- remove — To take away something from a place.removing
- circadian — A natural daily cycle in the body.
- immunotherapy — Treatment that uses the body's immune system.
- vaccine — Medicine given to make the body immune.
- cancer — A disease in which cells grow out of control.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you prefer immunotherapy in the morning if it works better? Why?
- Why is it important that immune cells can find cancer cells?
- Do you trust results from a small trial? Why?
Related articles
Gene and blood‑vessel damage add to dementia risk
Researchers studied a genetic variant (APOE ε4) and white matter hyperintensities (WMH), a sign of small blood‑vessel damage. They found both factors raise dementia risk additively, and vascular health may be improved to lower that risk.
Clock disruption speeds breast cancer in models
New research finds that repeating disruption of the body’s 24-hour clock changes breast tissue, weakens immune defenses and leads to faster, more aggressive breast cancer in experimental models. The study links altered light–dark schedules to worse outcomes.